Revisão Acesso aberto Revisado por pares

Drug resistance analysis by next generation sequencing in Leishmania

2014; Elsevier BV; Volume: 5; Issue: 1 Linguagem: Inglês

10.1016/j.ijpddr.2014.09.005

ISSN

2211-3207

Autores

Philippe Leprohon, Christopher Fernandez‐Prada, Élodie Gazanion, Rubens Lima do Monte‐Neto, Marc Ouellette,

Tópico(s)

Insect symbiosis and bacterial influences

Resumo

The use of next generation sequencing has the power to expedite the identification of drug resistance determinants and biomarkers and was applied successfully to drug resistance studies in Leishmania. This allowed the identification of modulation in gene expression, gene dosage alterations, changes in chromosome copy numbers and single nucleotide polymorphisms that correlated with resistance in Leishmania strains derived from the laboratory and from the field. An impressive heterogeneity at the population level was also observed, individual clones within populations often differing in both genotypes and phenotypes, hence complicating the elucidation of resistance mechanisms. This review summarizes the most recent highlights that whole genome sequencing brought to our understanding of Leishmania drug resistance and likely new directions.

Referência(s)